However, to the best of our knowledge, the present study is the first to demonstrate serum concentrations of ADAM15 in relation to well-established tumor markers for CRC, such as CEA and Ca 19-9, as well as a marker of inflammation—C-reactive protein (CRP). The gene discussed is CEACAM5; the disease is colorectal carcinoma.